Home > Quotes > AGN > Press Releases

Allergan, Inc. Press Releases

AGN 
$97.73
*  
0.81
  negative  
0.82%
Get AGN Alerts
*Delayed - data as of May 22, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face
05/02/2013 4:53PM - Business Wire

Allergan Reports First Quarter 2013 Operating Results
05/01/2013 9:00AM - Business Wire

Allergan Announces Death of Stephen J. Ryan, M.D.
04/30/2013 9:00AM - Business Wire

Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for LEVADEX® (dihydroergotamine) New Drug Application
04/16/2013 9:00AM - Business Wire

Allergan Announces Quarterly Conference Call
04/03/2013 5:00PM - Business Wire

Clearside Biomedical, Inc. Names Stephen H. Lang Vice President, Commercial Operations
03/04/2013 7:30AM - Business Wire

Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form Merger
03/01/2013 9:00AM - Business Wire